Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review.

anxiety disorders depression & mood disorders pain management sleep medicine substance misuse therapeutics

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
24 05 2020
Historique:
entrez: 26 5 2020
pubmed: 26 5 2020
medline: 15 5 2021
Statut: epublish

Résumé

Chronic pain and co-occurring disorders, such as sleep disorders, anxiety, depression, post-traumatic stress disorder and substance use disorders, are among the most common conditions for which cannabis and cannabinoid-based products derived from the cannabis plant (CBP) are used for therapeutic purposes. However, healthcare providers report that they lack sufficient information on the risks, benefits and appropriate use of cannabis and CBP derived from the cannabis plant for therapeutic purposes. We will conduct a systematic review of studies investigating the use of cannabis and CBP derived from the cannabis plant for the treatment of chronic pain and co-occurring conditions. Randomised controlled trials, meta-analyses and observational studies will be prioritised. We will exclude reviews of cannabinoid mechanisms of actions, commentary articles and narrative reviews. The primary outcome of interest will be efficacy in relieving chronic pain. Secondary outcomes will be efficacy in ameliorating conditions such as sleep disorders, anxiety, depression, post-traumatic stress disorder and substance use disorders. We will search electronic bibliographic databases including Academic Search Complete, Cochrane Database of Systematic Reviews, Evidence based Medicine Reviewes, OVID Medline, PsychINFO, PubMed, CINAHL and Web of Science. Two reviewers will conduct screening and data collection independently. Study level of bias will be assessed using the Cochrane Risk of Bias Assessment Tool for randomised controlled trials and non-randomised studies. Narrative analysis will be utilised to interpret the data. The results of this systematic review will inform guideline development for the use of cannabis and CBP derived from the cannabis plant in the management of chronic pain and co-occurring conditions. Areas requiring further study will also be highlighted. CRD42020135886.

Identifiants

pubmed: 32448797
pii: bmjopen-2019-036114
doi: 10.1136/bmjopen-2019-036114
pmc: PMC7253000
doi:

Substances chimiques

Analgesics, Opioid 0
Cannabinoids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036114

Subventions

Organisme : Canadian Institutes for Health Research
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Références

Drug Alcohol Depend. 2018 Feb 1;183:1-6
pubmed: 29220642
Sleep Med Rev. 2014 Dec;18(6):477-87
pubmed: 24726015
Pain. 2015 Apr;156(4):569-76
pubmed: 25785523
AIDS Care. 2007 Apr;19(4):500-6
pubmed: 17453590
JAMA Psychiatry. 2014 Jul 1;71(7):821-6
pubmed: 24871348
Pain. 2011 Mar;152(3):488-97
pubmed: 21185119
Cannabis Cannabinoid Res. 2016 Jan 01;1(1):44-46
pubmed: 28861479
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Int J Drug Policy. 2013 Nov;24(6):511-6
pubmed: 24095000
Eur J Intern Med. 2018 Mar;49:12-19
pubmed: 29307505
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Drug Alcohol Rev. 2015 Nov;34(6):654-9
pubmed: 25919477
J Pharmacol Pharmacother. 2014 Jul;5(3):203-5
pubmed: 25210401
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Cannabis Cannabinoid Res. 2017 May 01;2(1):96-104
pubmed: 28861509
Drug Alcohol Depend. 2003 Jul 20;71(1):7-16
pubmed: 12821201
Nat Prod Rep. 1999 Apr;16(2):131-43
pubmed: 10331283
Psychol Med. 2015 Apr;45(6):1121-33
pubmed: 25366671
Chem Biodivers. 2007 Aug;4(8):1729-43
pubmed: 17712817
Int Rev Psychiatry. 2018 Oct;30(5):136-146
pubmed: 30398071
J Opioid Manag. 2013 Jul-Aug;9(4):237
pubmed: 24380101
Br J Pharmacol. 2005 Dec;146(7):913-5
pubmed: 16205721
Subst Abuse Treat Prev Policy. 2017 Aug 15;12(1):36
pubmed: 28810899
BMJ. 2008 May 24;336(7654):1170-3
pubmed: 18497416
Schmerz. 2016 Feb;30(1):47-61
pubmed: 26767993
Drug Alcohol Depend. 1998 Nov 1;52(3):183-92
pubmed: 9839144
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
J Am Geriatr Soc. 2009 May;57(5):761-89
pubmed: 19484833
Clin Psychol Rev. 2017 Feb;51:15-29
pubmed: 27816801
Perspect Psychiatr Care. 2015 Oct;51(4):295-304
pubmed: 25420926
Pain Res Manag. 2002 Winter;7(4):179-84
pubmed: 12518174
BMJ. 2008 Jul 31;337:a744
pubmed: 18669566
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Drug Alcohol Rev. 2016 May;35(3):326-33
pubmed: 26364922
Depress Anxiety. 2009;26(10):888-901
pubmed: 19691031
Lancet Psychiatry. 2019 Dec;6(12):995-1010
pubmed: 31672337
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Drug Alcohol Depend. 2016 Mar 1;160:127-34
pubmed: 26785634
BMC Med Educ. 2015 Mar 19;15:52
pubmed: 25888752
JAMA. 2015 Jun 23-30;313(24):2456-73
pubmed: 26103030
Pain. 2007 Jul;130(1-2):144-56
pubmed: 17493754
Int J Drug Policy. 2014 Jul;25(4):691-9
pubmed: 24947993
J Neuroimmune Pharmacol. 2015 Jun;10(2):293-301
pubmed: 25796592
J Pain. 2016 Jun;17(6):739-44
pubmed: 27001005
Pain Res Manag. 2011 Nov-Dec;16(6):445-50
pubmed: 22184555
Int J Drug Policy. 2017 Apr;42:30-35
pubmed: 28189912
BMJ. 2008 May 10;336(7652):1049-51
pubmed: 18467413
J Public Health (Oxf). 2006 Dec;28(4):384-9
pubmed: 17082462
Pain Med. 2009 Nov;10(8):1353-68
pubmed: 19732371
Can J Public Health. 2015 Apr 30;106(5):e328-30
pubmed: 26451996
Psychosom Med. 2015 Apr;77(3):333-41
pubmed: 25849129
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631
Curr Opin Anaesthesiol. 2014 Oct;27(5):520-7
pubmed: 25188218
Drug Alcohol Depend. 2010 Jul 1;110(1-2):137-43
pubmed: 20347232
Am J Addict. 2010 Sep-Oct;19(5):409-15
pubmed: 20716303
Soc Sci Med. 2006 Aug;63(4):1060-71
pubmed: 16574289
CMAJ. 2017 May 8;189(18):E659-E666
pubmed: 28483845
Can Fam Physician. 2018 Feb;64(2):111-120
pubmed: 29449241

Auteurs

Patrick Wright (P)

Canadian AIDS Society, Ottawa, Ontario, Canada.

Zach Walsh (Z)

Department of Psychology, University of British Columbia, Kelowna, British Columbia, Canada.

Shari Margolese (S)

Canadian HIV Trials Network Community Advisory Board, Vancouver, British Columbia, Canada.

Tatiana Sanchez (T)

Department of Psychology, University of British Columbia, Kelowna, British Columbia, Canada.

Stephanie Arlt (S)

Canadian Institute for Substance Use Research,University of Victoria, Victoria, British Columbia, Canada.

Lynne Belle-Isle (L)

Canadian AIDS Society, Ottawa, Ontario, Canada.

Michelle St Pierre (M)

Department of Psychology, University of British Columbia, Kelowna, British Columbia, Canada.

Alan Bell (A)

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

Paul Daeninck (P)

Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Marilou Gagnon (M)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Gary Lacasse (G)

Canadian AIDS Society, Ottawa, Ontario, Canada gary.lacasse@cdnaids.ca.

Caroline MacCallum (C)

Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Enrico Mandarino (E)

Community Advisory, Canadian Institutes of Health Research Canadian HIV Trials Network, Vancouver, British Columbia, Canada.
MJardin Canada, Toronto, Ontario, Canada.

Janet Yale (J)

Arthritis Society of Canada, Toronto, Ontario, Canada.

James O'Hara (J)

Canadians for Fair Access to Medical Marijuana, Toronto, Ontario, Canada.

Cecilia Costiniuk (C)

Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH